课题基金 / 基金详情

Multiplex Nucleic Acid Detection Devices for the Diagnosis of Respiratory Viruses

Multiplex Nucleic Acid Detection Devices for the Diagnosis of Respiratory Viruses
用于诊断呼吸道病毒的多重核酸检测装置
批准号:
7649401
负责人:
Robert Turner Schooley
金额:
$79.53万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-06-30

项目摘要

项目成果

Robert Turner Schooley的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Influenza viral infections are a cause of major morbidity and mortality in humans as well as in wild and domesticated animal species. Influenza-related morbidity and mortality in humans is manifest on a yearly basis on the basis of ongoing genetic evolution of he virus in human and non-human species. Over the last several years, several strains of highly pathogenic Influenza A (H5N1) have arisen in wild and domestic bird populations. These viruses have already been transmitted to humans is a series sporadic predominantly bird-to-man transmission events. Infection with these highly pathogenic strains of H5N1 have been associated with mortality rates in man of 33 -100%. To date, cases of man-to-man spread have been difficult to document but there are substantial concerns that ongoing evolution of the virus might modify the transmissability of the agent over time. Accurate monitoring of circulating influenza strains in animal and human populations will greatly enhance our ability to anticipate and respond to the spread and/or evolution of both traditional and highly pathogenic strains of influenza and other retroviruses. In this application a collaborative group of virologists, microbial geneticists, genetic array experts, and physicists based at the University of California, San Diego and Precision Photonics in Boulder, Colorado propose to develop a novel and robust diagnostic platform that is capable of detecting respiratory virus nucleic acids in biological fluids at low cost, high sensitivity and rapid throughput. Refinements of the technology are proposed that will enable characterization of detected influenza viruses as to hemagglutinin and neuraminidase subtype, susceptibility to antiviral compounds and presence of targeted pathogenicity motifs. The platform can be expanded to include other respiratory viruses of man and could also be modified for veterinary use in either domestic or wild animal populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Sustained-Release Anti-HIV Nucleoside Phosphonate Nanoparticles
Development of Sustained-Release Anti-HIV Nucleoside Phosphonate Nanoparticles
Development of Sustained-Release Anti-coronavirus Nucleoside Phosphonate compounds
Orally Active Nucleoside Phosphonates for Hepatitis C Virus
海外基金